A Study to Explore Association Patterns Between Digital Outcome Assessments From the Konectom™ Platform and Magnetic Resonance Imaging (MRI) Measures of Brain Tissue Damage
NCT05106465 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 200
Last updated 2024-05-17
Summary
The purpose of the study is to explore association patterns between digital outcome assessments from Konectom and MRI measures of brain tissue damage.
Conditions
- Multiple Sclerosis (MS)
Interventions
- DEVICE
-
Konectom platform
Administered as specified in the treatment arm.
Sponsors & Collaborators
- lead INDUSTRY
Principal Investigators
-
Medical Director · Biogen
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2021-12-15
- Primary Completion
- 2024-04-03
- Completion
- 2024-04-03
- FDA Device
- Yes
Countries
- Germany
Study Locations
More Related Trials
-
Magnetic Resonance Imaging to Detect Brain Damage in Patients With Multiple Sclerosis
NCT00393588 ·Status: COMPLETED
-
Magnetic Resonance Imaging to Detect Brain Damage in Patients With Multiple Sclerosis
NCT00321568 ·Status: COMPLETED
-
MR Elastography of Cognitive Impairment
NCT06029114 ·Status: ENROLLING_BY_INVITATION
-
Investigation of GM Pathology Using Ultra High Field (7T) MRI Scanner
NCT01805986 ·Status: UNKNOWN
-
Functional MRI Biomarkers of Cognitive Decrements in Diabetes
NCT01705210 ·Status: COMPLETED
-
Study by Magnetic Resonance Imaging in the Progressive Forms of Multiple Sclerosis
NCT02580669 ·Status: TERMINATED ·Phase: NA
-
Quantitative Magnetic Resonance Imaging (MRI) Sub-Study of MS PATHS
NCT04145284 ·Status: COMPLETED
-
Multimodel Magnetic Resonance Imaging (MRI)of Multiple Sclerosis and Neuromyelitis Optica Spectrum Disorders
NCT02836327 ·Status: UNKNOWN
-
Safety and Efficacy Evaluation of DOTAREM® in MRI of Central Nervous System (CNS) Lesions
NCT01211873 ·Status: COMPLETED ·Phase: PHASE3
-
GTA-MEG as a Biomarker for Cognition in MS
NCT02851342 ·Status: COMPLETED
-
Refinement and Assessment of New Magnetic Resonance Imaging Technologies for Neurological Exams
NCT00739518 ·Status: COMPLETED ·Phase: NA
-
Multi-modality MRI Study on Prediction for Mild Cognitive Impairment Conversion
NCT02353884 ·Status: COMPLETED
-
Gadolinium and Ferumoxytol MRI in Diagnosing Patients With Abnormalities in the Central Nervous System
NCT03270059 ·Status: RECRUITING ·Phase: PHASE2
-
Non-Heme Iron Load Quantification in the Brain - MRI of Patients With Stroke
NCT01829386 ·Status: COMPLETED
-
Mobile MRI for Immediate Radiological Acute Cerebral Lesion Evaluation in Stroke
NCT06262217 ·Status: RECRUITING
-
Low Field Magnetic Resonance Imaging Assessment With Outpatients
NCT05582785 ·Status: RECRUITING ·Phase: NA
-
Combined Sensitivity and Specificity of Cortical Lesions and Central Vein Sign for MS Diagnosis and Differential Diagnosis
NCT04369898 ·Status: COMPLETED
-
Optimization and Harmonization of Advanced MRI Sequences
NCT06217237 ·Status: COMPLETED
-
Magnetic Resonance (MR) Spectroscopy and Diffusion Tensor Imaging in Determining Brain Injury and Subsequent Clinical Outcome in Patients of Moderate Brain Trauma
NCT00760903 ·Status: WITHDRAWN
-
Accurate Diagnosis of Multiple Sclerosis Using PET/MR
NCT04521439 ·Status: COMPLETED ·Phase: NA
-
Quantitative Imaging and Proton Spectroscopy in Multiple Sclerosis
NCT01226654 ·Status: TERMINATED ·Phase: NA
-
MR Perfusion Imaging and Hypercapnia (Increased Carbon Dioxide) to Study New Blood Vessel Formation in Multiple Sclerosis
NCT00064909 ·Status: COMPLETED
-
Metabolic and Structural Characterization of Hub's Vulnerability in Neurological Diseases Assessed by Ultra High Field Structural and Functional MRI
NCT03039166 ·Status: UNKNOWN ·Phase: NA
-
Development of Protocols and Methods for Image Processing and Enhancement of Magnetic Resonance Imaging (MRI) Data.
NCT04942704 ·Status: UNKNOWN
-
Imaging Biomarkers of Mild Traumatic Brain Injury: a Longitudinal Cohort Study
NCT02868684 ·Status: COMPLETED